Please scan the QR code to download the teleMEDCARE app (iOS and Android users).

Gene Therapy at Medcare Royal Speciality Hospital

Pioneering Precision Medicine for SMA & DMD

At Medcare Royal Speciality Hospital, we are at the forefront of genetic medicine, offering advanced gene therapy for patients with Spinal Muscular Atrophy (SMA) and Duchenne Muscular Dystrophy (DMD), two of the most challenging neuromuscular disorders.

Our expert multidisciplinary team utilizes the latest FDA-approved gene therapy protocols to target the root cause of these conditions, delivering life-changing treatments designed to slow disease progression and improve quality of life.

Our Areas of Expertise

Spinal Muscular Atrophy (SMA)

SMA is a severe neuromuscular disease that affects motor function and muscle strength. At Medcare Royal Speciality Hospital, we offer gene replacement therapy using the latest globally approved techniques to help halt disease progression and support motor development, especially when treated early in life.

Duchenne Muscular Dystrophy (DMD)

DMD is a genetic disorder that causes progressive muscle degeneration and weakness. Our gene therapy program is tailored to each patient's genetic profile and aims to restore dystrophin expression, improve mobility, and slow disease advancement.  

Why Choose Medcare Royal Speciality Hospital?

  • Specialized expertise in SMA & DMD care
  • Advanced diagnostic & genetic testing
  • Personalized care plans tailored to each patient
  • State-of-the-art facility with paediatric and adult support
  • Compassionate, lifelong follow-up care

We believe in not just treating diseases but empowering patients and families with knowledge, compassion, and hope. From diagnosis through post-treatment rehabilitation, our team walks beside every patient with expertise and empathy.

Resend OTP
Call Doctor Now
CALL DOCTOR NOW
REQUEST APPOINTMENT
Book a Maternity Tour